chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: Headache; Body ache; Tiredness; Congestion; Chill; Mild throat pain; Feeling tired; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 01Apr2021 at 16:30 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure and mild cardiomyopathy. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN) 20 (units unspecified), diltiazem (MANUFACTURER UNKNOWN) 60 mg and trazodone (MANUFACTURER UNKNOWN) 50 mg; all from unknown date for unknown indications. The patient previously received amoxicillin and codeine on unknown date for an unspecified indication and the experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 07:00, the patient experienced started feeling tired. On 07Apr2021, the patient experienced body ache, tiredness, congestion, chill and mild throat pain. On 08Apr2021, the patient experienced headache. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events feeling tired, body ache, tiredness, congestion, chill, mild throat pain and headache were not resolved at the time of reporting.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site reaction
Clinical narrative: "covid arm": round skin reaction under vaccination site on left arm/shoulder.; Raised/swollen vaccination site on left arm/shoulder.; painful vaccination site on left arm/shoulder.; red vaccination site on left arm/shoulder.; hot to the touch vaccination site on left arm/shoulder.; mildly itchy vaccination site on left arm/shoulder.; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0158) via an unspecified route of administration in the arm left on 06Apr2021 at 11:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), lamotrigine (LAMICTAL), ethinylestradiol, norethisterone acetate (JUNEL) and fexofenadine hydrochloride (ALLEGRA) all taken for unknown indication since unspecified dates. The patient previously took lorabid and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 21:00, the patient experienced vaccination site reaction, vaccination site swelling, vaccination site pain, vaccination site erythema, hot feeling in hand and itchy. It was reported that the patient had round skin reaction under vaccination site on left arm/shoulder. Raised/swollen, painful, red, hot to the touch and mildly itchy. The reactions started around 36 hours after the dose. The patient assumed this was common among patients though, given that she had read a lot of similar things on the internet. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the events vaccination site reaction, vaccination site swelling, vaccination site pain, vaccination site erythema, hot feeling in hand and itchy were not recovered at the time of this report.   No follow-up attempts are possible. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Cough, Headache, Hyperhidrosis
Clinical narrative: painful arm; chills; sweating; fever; nausea; coughing; extreme headache; joint pain; Difficulty sleeping; This is a spontaneous report from a contactable healthcare professional. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via intramuscular route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included long haul COVID. The patient had no allergies to medications, food, or other products. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN) and multivitamin (MANUFACTURER UNKNOWN), all taken for unknown indications from unknown dates. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 17:00, the patient experienced painful arm, chills, sweating, fever, nausea, coughing, extreme headache, joint pain and difficulty sleeping. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with tylenol and pain creams for joints. The clinical outcome of the events painful arm, chills, sweating, fever, nausea, coughing, extreme headache, joint pain and difficulty sleeping were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: painful arm; chills; sweating; fever; nausea; coughing; extreme headache; joint pain; Difficulty sleeping; This is a spontaneous report from a contactable healthcare professional. A 46-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via intramuscular route of administration in the left arm on 31Mar2021 at 14:00 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included long haul COVID. The patient had no allergies to medications, food, or other products. Concomitant medications included meloxicam (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN) and multivitamin (MANUFACTURER UNKNOWN), all taken for unknown indications from unknown dates. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 31Mar2021 at 17:00, the patient experienced painful arm, chills, sweating, fever, nausea, coughing, extreme headache, joint pain and difficulty sleeping. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with tylenol and pain creams for joints. The clinical outcome of the events painful arm, chills, sweating, fever, nausea, coughing, extreme headache, joint pain and difficulty sleeping were resolved on an unknown date in Apr2021.  No follow-up attempts are needed. No further information is expected.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Discomfort
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 43-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP7534) via an unspecified route of administration in the left arm on 05Apr2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history includes penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021, at 21:00, 12 hours after injection, the patient experienced chills, joint pain and general discomfort. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of event. The clinical outcome of the events chills, joint pains and general discomfort was recovered on an unknown date at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Ear pain, Pain in jaw, Tinnitus
Clinical narrative: Strong metallic taste; Ringing in the right ear/Primarily in right ear but noticeable in left as well; Pain up through jaw within 5 minutes of injection; Pain  into right ear within 5 minutes of injection; This is a spontaneous report from a contactable healthcare professional, the patient. A 52-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the right arm on 24Feb2021 at 14:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and known drug allergy. The patient did not receive any other medications within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Feb2021 at 14:05, the patient experienced pain up through jaw and into right ear within 5 minutes of injection. On 24Feb2021 at 14:15, the patient experienced strong metallic taste and a ringing in the right ear, which was continued to get worse. Primarily the ringing in the right ear but noticeable in the left as well. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events pain up through jaw and into right ear within 5 minutes of injection, strong metallic taste and a ringing in the right ear, primarily in the right ear but noticeable in the left as well was not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the right arm on 17Mar2021 (at the age of 52-years-old) as a single dose for COVID-19 immunisation.  No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: A rather large lymph node in left armpit; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 05Apr2021 at 08:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. The patient did not have any allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 08Mar2021 at 08:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 07:00 (next morning after receiving 2nd dose of vaccine), the patient had a rather large lymph node in left armpit. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. The clinical outcome of the event a rather large lymph node in left armpit (lymphadenopathy) was not resolved at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: I vomited once and had diarrhea the night after getting my second dose of the vaccine.; I vomited once and had diarrhea the night after getting my second dose of the vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8733) via an unspecified route of administration in the arm left on 26Mar2021 at 11:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Medical history included depression, anxiety, chronic eye issues and penicillin allergy. Concomitant medications included escitalopram oxalate (LEXAPRO) and doxepin (MANUFACTURER UNKNOWN); for unknown indication from an unspecified date. The patient previously received vicodin (MANUFACTURER UNKNOWN) for unknown indication on an unspecified date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN 6206) via an unspecified route of administration in the arm left on 05Mar2021 at 10:00 (at the age of 34-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 01:00, the patient vomited once and had diarrhea the night after getting the second dose of the vaccine. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events vomiting was recovered on 27Mar2021; while that of the event diarrhea was recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Vomiting
Clinical narrative: Vomiting for 24 hours; not feeling like moving; headache; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8734), via an unspecified route of administration in the left arm on 05Apr2021 at 16:30 (at the age of 17-year-old), as a single dose for COVID-19 immunisation. Medical history included pandas. Concomitant medications included LEXAPRO, naltrexone (MANUFACTURER UNKNOWN), hydroxyzine (MANUFACTURER UNKNOWN), VITAMIN D, PROBI from an unknown start date within 2 weeks of vaccination to an unknown stop date and unknown if ongoing. The patient was allergic to amoxicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 02:00, the patient experienced vomiting for 24 hours, headache and the patient did not feel like moving. Therapeutic measures were not taken as the result of the reported event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, vomiting for 24 hours and not feeling like moving was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Influenza like illness, Pain, Pain in extremity
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine, lot number: ER8732) via an unspecified route of administration in the right arm on 02Apr2021 at 13:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received morphine (MANUFACTURER UNKNOWN) for unknown indication and unknown date and experienced allergy. Concomitant medications included desogestrel, ethinylestradiol (PRIMERA) and progesterone (MANUFACTURER UNKNOWN) for unknown indication and unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 02Apr2021, the patient experienced sore from shot, flu like symptoms, ache and tiredness on the night of vaccination. On 08Apr2021, reported as 6 days after shot she had dizziness and vertigo. On an unspecified date in Apr2021, the patient experienced sore arm for a few days. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore from shot, flu like symptoms, ache, tiredness, dizziness, vertigo and sore arm were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vertigo
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 MRNA vaccine, lot number: ER8732) via an unspecified route of administration in the right arm on 02Apr2021 at 13:45 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received morphine (MANUFACTURER UNKNOWN) for unknown indication and unknown date and experienced allergy. Concomitant medications included desogestrel, ethinylestradiol (PRIMERA) and progesterone (MANUFACTURER UNKNOWN) for unknown indication and unknown date. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 02Apr2021, the patient experienced sore from shot, flu like symptoms, ache and tiredness on the night of vaccination. On 08Apr2021, reported as 6 days after shot she had dizziness and vertigo. On an unspecified date in Apr2021, the patient experienced sore arm for a few days. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events sore from shot, flu like symptoms, ache, tiredness, dizziness, vertigo and sore arm were not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Malaise, Nausea, Vertigo, Vomiting
Clinical narrative: felt very weak; felt dizzy; nauseous; Laid down and couldnt even move head as room was spinning.; vomited; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 09:45 (at the age of 65-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no allergies to medications, food or other products. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 12:30, after 2 hours of vaccination, the patient felt dizzy and nauseous. The patient did lie down and couldn't even move her head as room was spinning. The patient tried to get up but made her more nauseous and vomited. The patient stayed in bed all day and at and the next day on 28Mar2021, the patient still had little nausea and felt very weak. By evening the patient was able to eat. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events dizziness and nausea which included treatment with DRAMAMINE. No therapeutic measures were taken as a result of the events head spinning, vomited and felt very weak. The clinical outcomes of the events dizzy, nauseous, laid down and couldn't even move the head as room was spinning, vomited and felt very weak was recovered on an unknown date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: severe chest pain that would come and go every 20-30 minutes in sharp increments; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 05Apr2021 at 10:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation.  The patient had no medical history reported. The patient did not have any allergies to medications, food, or other products. The patient did not receive any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15Mar2021 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 10:45, 24 hours after receiving the second dose of vaccine, the patient experienced severe chest pain that would come and go every 20-30 minutes in sharp increments. That lasted about 7 to 8 hours. The pain was concentrated in the middle of the patient's chest. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event severe chest pain that would come and go every 20-30 minutes in sharp increments. The clinical outcome of the event severe chest pain that would come and go every 20-30 minutes in sharp increments was resolved on 06Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Headache
Clinical narrative: Headache; joint pain; chills; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration on 06Apr2021 at 16:30(at the age of 64-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Concomitant medications were not included. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 06Apr2021 at 16:30, the patient experienced headache, joint pain and chills. On the other hand, the patient thought that way more than 4% of those vaccinated experience a little something, should not be afraid if feel something. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, joint pain and chills was recovering.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Blister, Herpes simplex, Pyrexia
Clinical narrative: Herpes simplex 1; Fever; Blister in nose; This is a spontaneous report from a contactable other health care professsional. A 40-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), dose 1 via an unspecified route of administration, administered in Arm Left on 10Mar2021 at 13:45 (Age at vaccination: 40 years) as dose 1, single for covid-19 immunization. Medical history was None. Concomitant medications included ESTRADIOL patch 0.75. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced herpes simplex 1, fever and blister in nose on an unknown date. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The outcome of the events was recovering.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Vaccination site pain
Clinical narrative: Fatigue; Pain at injection site; Joint soreness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 06Apr2021 at 17:00 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. The patient did not have any medical history and had no known allergies to food, medications and other products. Concomitant medications included birth control medication (unspecified). The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 19:00, the patient experienced fatigue, pain at injection site, joint soreness and headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fatigue, pain at injection site, joint soreness and headache was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia
Clinical narrative: Metal taste in mouth; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 05Apr2021 at 14:45 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have allergy to any medications, food, or other products. The patient did not take any medications within two weeks prior to vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 15:15 the patient experienced metal taste in mouth. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event metal taste in mouth was resolving at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on right hip; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration on 30Mar2021 (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had known allergies to penicillin (MANUFACTURER UNKNOWN). Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), from an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Apr2021, the patient experienced rash on right hip. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of rash on right hip was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Muscle soreness at injection site; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Apr2021 at 19:30 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension from an unknown date. Concomitant medications included atorvastatin (MANUFACTURER UNKNOWN)  and lisinopril (MANUFACTURER UNKNOWN); both from unknown dates for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Apr2021 at 11:00, the patient experienced muscle soreness at injection site that lasted approx. 24 hours. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event muscle soreness at injection site was recovered on an unknown date in Apr2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Feeling cold
Clinical narrative: Cold sensation down arm below elbow to hand (by thumb).; Burning sensation down arm below elbow to hand (by thumb); This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient did not have any known allergies to medications, food or other products. The patient did not receive any medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 08Apr2021 at 11:15, the patient experienced cold and burning sensation down arm below elbow to hand (by thumb). The patient reported that this occurred on and off for about 20-30 minutes after and was first felt 20 minutes after the injection. The events did not result in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event cold and burning sensation down arm below elbow to hand (by thumb). The clinical outcomes of the events cold and burning sensation down arm below elbow to hand (by thumb) was resolved on 08Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Later tingly/numb feeling hand, arm, neck, face (left side); Within 15 minutes tingly hand, later tingly/numb feeling hand, arm, neck, face (left side); This is a spontaneous report from a contactable consumer, the patient. A 55-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 02Apr2021 at 14:45 (at the age of 55-year-old) as a single dose for COVID-19 immunisation. No relevant medical history. Concomitant medications included multivitamin (MANUFACTURER UNKNOWN), withania somnifera (ASHWAGANDHA), fish oil (MANUFACTURER UNKNOWN) and mentha x piperita oil (PEPPERMINT OIL), all from unknown date for unknown indication taken within 2 weeks of vaccination. The patient previously took naproxen (MANUFACTURER UNKNOWN) on an unknown date for an unknown indication and experienced allergy. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 02Apr2021 within 15 minutes of vaccination, at 15:00 the patient experienced tingly hand. Later, on 02Apr2021 at 15:15 the patient experienced tingly/numb feeling hand, arm, neck and face (left side).No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event tingly hand(Paraesthesia) and tingly/numb feeling hand, arm, neck, face on left side (Hypoesthesia) were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Palatal swelling
Clinical narrative: Swelling of the palate; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 11:00 (at the age of 60-year-old) as a single dose and also received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 02Apr2021 at 13:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had a history of allergy to penicillin. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. On 24Mar2021, the patient had experienced swelling of the palate. The patient did not receive any treatment for the reported event. The adverse event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event swelling of the palate was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Pain in extremity
Clinical narrative: Feeling/sensation in upper arm below injection site. (Not painful); A painful and uncomfortable feeling went into the middle finger of same arm .; A painful and uncomfortable feeling in joint of same arm; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep6955) via an unspecified route of administration in the left arm on 26Mar2021 at 15:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. The patient's medical history was not provided. The patient had no known allergies to medications, food, or other products. Concomitant medication included celecoxib (CELEBREX) taken for an unknown indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 26Mar2021 at 15:45, within 30 min of receiving the shot, the patient reported that as she was driving home, she experienced a feeling/sensation in her upper arm below injection site which was not painful. The patient reported that the feeling then went into her middle finger/ joint of the same arm, it was a painful and uncomfortable feeling. The pain increased throughout the remainder of the day. The patient reported that the pain in the joint did not seem to subside even after she iced her finger. The patient still had terrible pain in the joint on that day (at the time of reporting). She had been icing as much as possible. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of pain in joint and middle finger and included icing the finger and joint. The clinical outcome of the event feeling/sensation in the upper arm below injection site which was not painful and pain in joint and middle finger was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Muscle spasms, Pyrexia
Clinical narrative: Headache; Body Cramps; Fever; Chills; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 08:45 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Medical history included fruit allergy towards mango. The patient did not receive any other concomitant medications within 2 weeks prior to the vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 16Mar2021 at 08:00 (at the age of 27-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 23:00, the patient experienced headaches, body cramps, fever, chills and fatigue. The patient did not receive any treatment for the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, body cramps, fever, chills and fatigue was recovering at the time of the report.   No follow-up attempts are needed. No further information is expected.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal discomfort
Clinical narrative: Feels like my throat is falling asleep like when eat ginger; This is a spontaneous report from a contactable pharmacist. A 27-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via intramuscular route of administration in the right arm on 17Mar2021(at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, type 2 diabetes mellitus, and COVID 19. It was unknown if patient was pregnant at the time of vaccination. Concomitant medications included metformin hydrochloride (METFORMIN), lisinopril (MANUFACTURER UNKNOWN) and hydrochlorothiazide (HCTZ); all from unknown date and for unknown indication. The patient was allergic to ibuprofen (MOTRIN) and ginger. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient received tetanus vaccine toxoid, diphtheria vaccine toxoid, pertussis vaccine acellular 3-component (BOOSTRIX) on 03Mar2021 within four weeks prior to the COVID vaccine. On 17Mar2021, the patient experienced throat felt asleep like when she ate ginger. Therapeutic measures were taken as a result of event and included treatment with BENADRYL 50mg capsule. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  The clinical outcome of the event throat felt asleep when she ate ginger was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Lethargy, Pain, Pyrexia
Clinical narrative: Chills; 102 degrees temperature; Lethargic; Achy; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 06Apr2021 at 19:30 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Concomitant medications were not reported. The patient did not receive any other medications within two weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient body temperature was measured and the result was 102 degrees. On 07Apr2021 at 00:00, the patient experienced chills, 102 degrees temperature, lethargic and achy. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event.  The clinical outcome of the event chills ,102 degrees temperature, lethargic and achy was not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Fatigue, Headache
Clinical narrative: Headache; Extreme tiredness; Felt dizzy; Chills; This is a spontaneous report from a contactable consumer, the patient. A 42-years-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 16:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The relevant medical history was not reported. The patient had known allergies to sulfa (sulfonamide). Concomitant medications included fluoxetine hydrochloride (PROZAC), diazepam (MANUFACTURER UNKNOWN), eleutherococcus senticosus root (GINSENG), docosahexaenoic acid, eicosapentaenoic acid, tocopherol (OMEGA 3) and Multivitamins from on an unknown date, for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Mar2021 at 15:00 i.e. 2 hours after the vaccination, the patient felt dizzy, out of it and chills. Fine for a week i.e. On 24Mar2021, patient experienced extreme tiredness, hard to exercise and headache. stop happening 3 weeks later. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the event felt dizzy and chills was recovered on an unknown date in Mar2021. The clinical outcome of  extreme tiredness, hard to exercise and headache was recovered (stop happening 3 weeks later) i.e. on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Fatigue, Feeling abnormal, Headache
Clinical narrative: Hives on lower trunk; Vaccination site pain; Fatigue; Headache; Chills; Body aches; Fever 99.4; Nausea; General malaise; Brain fog; Swollen lymph nodes; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 03Apr2021 at 17:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included controlled depression, anxiety, COVID-19 and mildly intolerant to gluten. Patient was allergic to ibuprofen (MOTRIN). Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) 15mg and ethinylestradiol, drospirenone (NIKKI); both from an unknown date and for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 03Apr2021 at 20:00, the patient experienced hives on lower trunk and extremities continuing 96 hours after administered, injection site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, and swollen lymph nodes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. On 03Apr2021, the patient body temperature was measured and the result was 99.4 (units unspecified). The clinical outcome of the event hives on lower trunk, vaccination site pain, fatigue, headache, chills, body aches, fever 99.4, nausea, general malaise, brain fog, swollen lymph nodes were recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.